AtlantiCare
en Español
 
AboutHealth ServicesHealth ConditionsLocationsEvents & CoursesCommunityWays of Giving
  Search  
 
Health News
Today's Headlines
Health Alerts
Health News Feature
Future of Medicine
Health Observances
Product Recalls
Health Library
Illnesses & Conditions
Drug Guide
FDA Drug Approvals
Medical Tests
Self-Help Resources
Complementary Medicine
Medline Search
Health Topics
Allergies
Asthma
Back Pain
Cancer
Caregiver
Depression
Diabetes
GERD
Heart
Kidney
Men's Health
Orthopedic
Parenting
Patient Safety
Pregnancy
Senior
Stress
Stroke
Weight Mgmt
Women's Health
Healthy Living
Fitness
Nutrition
Mind & Body
Family & Home
Today's Headlines

Health News
Daily articles from HealthDay News: breaking news on health issues, drug approvals and recent discoveries.

Blocking Drug-Related Memories May Prevent Relapses


Animal brain receptor study suggests new treatments for addiction in humans

WEDNESDAY, Aug. 13 (HealthDay News) -- It may be possible to prevent a drug addiction relapse by disrupting the brain's attempts to retrieve drug-associated memories, according to new research.

U.K. researchers reduced drug-seeking behaviors in rats by blocking their brain's NMDA-type glutamate receptor, which is vital for learning and memory, during the recall of drug-associated memories. Researchers have known that recalling memories linked to previous drug use, such as environmental cues, can cause recovering drug addicts to relapse.

The findings are published in the Aug. 13 issue of The Journal of Neuroscience.

In the study, researchers at the University of Cambridge trained rats to associate a light going on with receiving a dose of cocaine. They "reactivated" the memory by exposing the rats to the light without the cocaine infusion. Later, the rats continued to perform behaviors that turned on the light or learned to perform new behaviors to try to get more cocaine.

The rats' cocaine-seeking behaviors were reduced after the researchers gave the animals a chemical that interfered with the NMDA-type glutamate receptor. When the single treatment was given just prior to the reactivation session, it reduced or even stopped drug-seeking behavior for up to a month; however, when given after or without the reactivation session, it had no effect on subsequent drug-seeking behaviors.

The findings suggest combining existing therapy with properly timed use of NMDA receptor inhibitors may help addicts kick their habits. The U.S. Food and Drug Administration already has approved several NMDA receptor inhibitors, including the cough suppressant dextramethorphan and the Alzheimer's disease drug memantine.

More information

The Center for Substance Abuse Treatment has more about dealing with addiction.

SOURCE: Society for Neuroscience, news release, Aug. 12, 2008
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Health News Provided By:
HealthDay
 
 
Notice of Privacy Practices | | Disclaimer    © 2006 AtlantiCare AtlantiCare Access
 

  Powered by HEALTHvision